Product description

Fertibiome® is an innovative probiotic solution specifically designed to reverse urogenital dysbiosis in couples to improve reproductive health.
It is formulated with the exclusive patented strain Ligilactobacillus salivarius PS11610 and is supported by a clinical trial that achieved the following results:
Significant reduction of pathogenic bacteria after 3 and 6 months of treatment. Restoration of microbial balance in the male and female urogenital tract. 
Improvement of the uterine immune state by reducing inflammation. 

Additionally, a recently published retrospective study evaluated the impact of the Fertibiome® probiotic strain Ligilactobacillus salivarius PS11610 on in vitro fertilization (IVF) treatment outcomes. The study demonstrated improvement in IVF success rates with frozen embryo transfers. 
Supplementation with Fertibiome® is a promising tool in assisted reproduction treatments, improving pregnancy outcomes and live birth rates.
We are currently running up the second clinical trial.

Read more

Specifications

Categories Probiotics
Supplied from Spain
Product Applications Food Supplements

More products from ZINEREO PHARMA

Products from other suppliers